Scientist whose work led FDA to ban food dye says agency overstated risk

FHS
March 17, 2025
10:39 am

When the FDA announced in January, before President Joe Biden’s term ended, that it would ban a dye called red dye No. 3 in food and ingested drugs, the federal agency cited just one 1987 study on rats to support its action.

Favorable Long-Term Results With Ranibizumab Implant for Neovascular AMD

The ranibizumab port delivery system (PDS; Susvimo) with 6-month refill maintained noninferiority to monthly intravitreal injections for neovascular age-related macular degeneration (nAMD) out to 2

July 8, 2023

MarketingRx roundup: Study finds generic drugs gain ground, but docs still prefer brands; Pfizer lauded at AACR

Generic drugs still passed over for brands, study finds: While more doctors are prescribing generic drugs, the majority of doctors still prefer brand name drugs,

April 10, 2024

Resmetirom Poised to Become First NASH Treatment

Groundbreaking results from a phase III trial have set the stage for resmetirom to become the first drug approved for patients with nonalcoholic steatohepatitis (NASH)

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.